Biotech Values

[ThomasS]

MNTA: "Therefore, the fact that Teva has agreed to a drawn-out timeline in which a trial could not start until 2013 suggests that Teva has no expectation of getting FDA approval in the next two years."

I believe what may be lost in this discussion is the obvious fact that NVS/MNTA must also have no expectation of Teva garnering an imminent approval. Didn't NVS/MNTA have to agree to the timeline?